ROYAL BANK OF CANADA - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$13,000
-86.7%
2,370
-83.9%
0.00%
Q2 2023$98,000
+22.5%
14,689
+62.4%
0.00%
Q1 2023$80,000
-50.9%
9,043
-57.7%
0.00%
Q4 2022$163,000
+328.9%
21,388
+298.5%
0.00%
Q3 2022$38,000
-7.3%
5,367
+4.9%
0.00%
Q2 2022$41,000
-63.1%
5,117
-36.2%
0.00%
Q1 2022$111,000
-22.9%
8,017
+56.2%
0.00%
Q4 2021$144,000
-27.6%
5,132
-12.5%
0.00%
Q3 2021$199,000
-21.7%
5,862
-5.6%
0.00%
Q2 2021$254,000
-58.4%
6,212
-59.0%
0.00%
Q1 2021$611,000
+627.4%
15,158
+962.2%
0.00%
Q4 2020$84,000
+110.0%
1,427
+75.3%
0.00%
Q3 2020$40,000
-98.6%
814
-98.7%
0.00%
-100.0%
Q2 2020$2,952,000
+69.6%
61,003
-2.7%
0.00%0.0%
Q1 2020$1,741,000
+1972.6%
62,682
+2144.3%
0.00%
Q4 2019$84,000
-75.6%
2,793
-75.0%
0.00%
Q3 2019$344,000
+17.4%
11,179
+84.6%
0.00%
Q2 2019$293,0006,0550.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders